Study shows phototherapy does not cause systemic inflammation
A study found phototherapy, a commonly used treatment for neonatal jaundice, does not lead to systemic inflammation in infants.
A study found phototherapy, a commonly used treatment for neonatal jaundice, does not lead to systemic inflammation in infants.
A recent case report described how an infant was diagnosed with anti-C HDFN despite not showing physical indicators of HDFN.
Practices for alloimmunization prevention and future HDFN management during medical abortions vary significantly among physicians.
New guidelines were published recently surrounding HDFN prevention during the first trimester of pregnancy.
Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect vaccine efficacy.
A cohort study of 20 pregnancies complicated by HDFN highlights the correlation between early diagnosis and favorable outcomes.
Determining fetal RhD status early in RhD-negative pregnancies could help prevent the unnecessary administration of anti-D immunoglobulin.
IUTs are often required to treat HDFN, and the intrahepatic intraperitoneal approaches appear to be superior to other techniques.
Increased testing for Rh and Kell phenotypes could reduce the risk of adverse transfusion reactions and HDFN, a study found.
The application of the AAP in a maternal health care facility significantly improved the timely evaluation of HDFN.